BiotechTube
LYNE LABS

LYNE LABS

Boston, United States· Est.
lyne.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

LYNE LABS is an established, private CDMO with deep roots in pharmaceutical manufacturing, particularly in oral liquid and solid dosage forms. The company leverages specialized technologies in powder processing, taste masking, and unit-dose packaging to serve generic and branded drug developers. With a leadership team boasting decades of industry experience and a recent facility expansion for high-concentration flammable products, LYNE is positioned for growth in the outsourced pharmaceutical manufacturing market. Its business model is centered on contract services and strategic alliances rather than internal therapeutic development.

Drug DeliveryBiologics

Technology Platform

Specialized expertise in powder technology (particle engineering, taste masking), liquid dosage form development, and unit-dose packaging for pharmaceuticals.

Opportunities

The growing outsourcing trend in pharma, coupled with shortages in complex oral liquid generics, creates strong demand for LYNE's specialized CDMO services.
Expansion into manufacturing high-potency and flammable products opens doors to the lucrative oncology and potent API market.
Their legacy in patient-friendly unit-dose packaging aligns with industry shifts towards improved medication adherence and safety.

Risk Factors

LYNE faces intense competition from larger, well-capitalized CDMOs and relies on a limited number of client projects for revenue.
Its business is highly sensitive to regulatory compliance; any significant FDA or quality issue could be catastrophic.
Future growth is dependent on the success of its strategic alliance model and the ongoing adoption of its proprietary technologies by partners.

Competitive Landscape

LYNE competes in the fragmented CDMO market, facing giants like Catalent, Lonza, and Recipharm, as well as numerous smaller specialists. Its differentiation lies in its deep, niche expertise in liquid formulations and unit-dose packaging, areas where larger players may not focus. However, it lacks the global scale and broad service offerings of its largest competitors.

More companies in United States →